UNSPSC 51384612: Kebuzone or ketophenylbutazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H18N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4VD83UL6Y6, chemically known as 3,5-pyrazolidinedione, 1,2-diphenyl-4-(3-oxobutyl)- but generally known as kebuzone, which bears US NIH Compound Identifier 3824. European Medicines Agency schedules Kebuzone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08363MIG.

UNSPSC 51384612 Kebuzone or ketophenylbutazone is a Commodity code that shows minimal alignment with actual state and local procurement activity. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and drug deactivation systems for community health initiatives, which falls entirely outside the pharmaceutical anti-inflammatory scope nominally described by the code name. The mismatch suggests either miscoding by the issuing body or a data-source classification error rather than active procurement demand for kebuzone or ketophenylbutazone products at the state and local level.

Seminole County's solicitation, posted June 30, 2026 with a response deadline of July 26, 2023, represents the only recent activity available in the source. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries required to the Seminole County Community Health Building in Sanford, Florida. The procurement was issued as a competitive IFB with a two-year initial term and one-year renewal option, requiring vendors to include all shipping and delivery costs in their bids and maintain workers' compensation, commercial general liability, and professional liability insurance. No explicit set-aside designations were noted. Without additional recent opportunities coded to this UNSPSC number, the code does not signal actionable state and local procurement activity for kebuzone or ketophenylbutazone products.